Table: Mochida Pharm -2018/19 group results

Mochida Pharmaceutical

13/05/2019 06:00

May 13 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          109.64          106.76         103.00                 
               (+2.7 pct)      (+9.7 pct)     (-6.1 pct)               
  Operating       10.59           11.66           7.70                 
               (-9.2 pct)      (+2.5 pct)     (-27.3 pct)              
  Recurring       10.93           12.01           8.10                 
               (-9.0 pct)      (+3.1 pct)     (-25.9 pct)              
  Net
  Net              8.44            9.02           5.80                 
               (-6.5 pct)      (+5.8 pct)     (-31.2 pct)              
  EPS          212.87 yen      227.27 yen     147.85 yen               
  Ann Div      170.00 yen      170.00 yen      80.00 yen               
  -Q2 Div       80.00 yen       72.50 yen      40.00 yen               
  -Q4 Div       90.00 yen       97.50 yen      40.00 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T